# Nuedexta in Treatment-Resistant Major Depression

> **NCT01882829** · PHASE2 · COMPLETED · sponsor: **James Murrough** · enrollment: 20 (actual)

## Conditions studied

- Major Depressive Disorder
- Treatment Resistant

## Interventions

- **DRUG:** dextromethorphan/quinidine

## Key facts

- **NCT ID:** NCT01882829
- **Lead sponsor:** James Murrough
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01882829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01882829, "Nuedexta in Treatment-Resistant Major Depression". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01882829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*